To illustrate the potential clinical and economic benefits of improved medication adherence among patients with diabetes covered by Medicaid in each state, the Medicaid Diabetes Adherence Online Tool was developed to help visualize the simulated 10-year outcomes from the following three hypothetical scenarios using the Disease Prevention Microsimulation Mode:
The tool is formatted for use on a desktop device only.
More than 30 million people in the United States are living with diabetes, and about 5 million of them are covered by Medicaid. Individuals living in poverty are more likely to develop diabetes and related complications such as cardiovascular disease, kidney disease, blindness, nerve damage, and amputation.
These serious conditions contribute to early mortality and create a substantial economic burden, including missed days of work or loss of productivity. As the largest public source of insurance for the low-income population, Medicaid program spent more than $25 billion on diabetes-related treatment in 2013.